-The Times of India NEW DELHI: Civil society members and RTI activists sharply criticized political parties for their reluctance to accept the Central Information Commission (CIC) order bringing them under the RTI Act. In a reflection of their cautious stance, the Association for Democratic Reforms (ADR) - the main applicant who had sought information on donors to political parties - filed a caveat on Tuesday with the court to prevent any...

-The Times of India NEW DELHI: Concern over the anti-Naxal policies not yielding desired results despite massive fund allocations and ambitious development schemes found voice at the meeting of the UPA coordination committee meeting on Monday. The discussion, held in the wake of a massacre of Congress leaders in Chhattisgarh on May 25, saw leaders pondering whether the government is getting it right in terms of its policy efforts and needs to...

-The Telegraph Imphal: A Manipuri widow's cry for justice rang out during the 23rd session of the UN Human Rights Council this morning, as she questioned gaps in UN Special Rapporteur on extrajudicial, summary or arbitrary executions Christof Heyns's report on the Armed Forces (Special Powers) Act. Neena Ningobam, who represented the Extrajudicial Execution Victim Families' Association, Manipur, of which she is the secretary, and the Asian Legal Resource Centre (ALRC) at...

-The Business Standard After the US and Indian authorities, the medicines manufactured by Ranbaxy Laboratories are now under the scanner of Hospitals, too. Mumbai's leading Jaslok Hospital has already put up a notice advising its doctors to avoid prescribing Ranbaxy drugs, while some others are reviewing the matter. Medanta Medicity officials say they will soon assess the situation and take a decision. "I have received around a dozen queries from patients recently....

-The Times of India MUMBAI: A Mumbai hospital has put up a notice advising its doctors to avoid prescribing drugs manufactured by Ranbaxy Laboratories. This comes a fortnight after Ranbaxy Laboratories agreed to pay a $500-million penalty to US authorities for "selling adulterated drugs" in the American market. It is not known whether the two are linked. Consultants at Jaslok Hospital said an advisory was put up at the receptionist's circular desk...